Udg Healthcare PLC (LON:UDG) had its price target lifted by Berenberg Bank from GBX 655 ($8.11) to GBX 700 ($8.66) in a research note released on Friday. They currently have a buy rating on the stock.
Other analysts also recently issued research reports about the company. Numis Securities Ltd restated an add rating and issued a GBX 675 ($8.35) price target on shares of Udg Healthcare PLC in a research note on Thursday, August 4th. Jefferies Group upped their price target on Udg Healthcare PLC from GBX 630 ($7.80) to GBX 680 ($8.42) and gave the stock a buy rating in a research note on Tuesday, July 26th. Goodbody restated a buy rating on shares of Udg Healthcare PLC in a research note on Thursday, August 4th. Stifel Nicolaus restated a hold rating and issued a GBX 620 ($7.67) price target on shares of Udg Healthcare PLC in a research note on Wednesday, September 28th. Finally, Davy Research restated an outperform rating on shares of Udg Healthcare PLC in a research note on Thursday, August 4th. Two research analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. The company presently has a consensus rating of Buy and a consensus target price of GBX 666 ($8.24).
Udg Healthcare PLC (LON:UDG) opened at 642.00 on Friday. The stock’s market capitalization is GBX 1.58 billion. The stock has a 50 day moving average price of GBX 633.23 and a 200 day moving average price of GBX 604.63. Udg Healthcare PLC has a 12 month low of GBX 452.20 and a 12 month high of GBX 663.00.
In other Udg Healthcare PLC news, insider Chris Corbin sold 90,849 shares of the stock in a transaction on Monday, September 26th. The stock was sold at an average price of GBX 634 ($7.85), for a total transaction of £575,982.66 ($712,849.83).